http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0563134-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_571b8abacacea64d3f7089d0983b8b3b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate | 1991-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c148e926ad3167dc482ba0beb6f6f3e7 |
| publicationDate | 1993-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0563134-A1 |
| titleOfInvention | AGENTS FOR REINFORCING THE EFFECT OF ANTITUMORAL AGENTS AND FOR RESISTANCE TO MULTIPLE DRUGS. |
| abstract | Potentiation agents used to increase the effectiveness of anticancer agents. These potentiating agents are the alpha-aryl-4-substituted derivatives of piperidinoalkanol such as terfenadine, the 11- (4-piper-dylidene) -5H-benzo- [5,6] -cyclohepta- [1,2-b ] -pyridines such as Loratadine, and N-heterocyclyl-4-piperidinamines where the heterocyclic radical is a 1H-benzimidazol-2-yl or 3H-imidazo [4,5-b] pyridin-2-yl radical optionally substituted as than astemizole. |
| priorityDate | 1990-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 379.